Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1487709

CCC(C)CC(C)N.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL243596 0.97
SCHEMBL17887523 0.97
SCHEMBL14820104 0.97
SCHEMBL17887506 0.97
SCHEMBL14450181 0.97
SCHEMBL24223118 0.91 ALDH1A1 (0.45)
Bicarbonate SCHEMBL3365786 0.84 SLC1A3 (0.41)
SCHEMBL10532743 0.84 ALDH1A1 (0.39)
SCHEMBL22236935 0.82 ALDH1A1 (0.43)
SCHEMBL803810 0.79 ALDH1A1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103467303-B Preparation method of 1, 3-dimethyl-pentylaminehydrochloride SHANGHAI INST TECHNOLOGY 2015-03-04 CN claimed
CN-103467303-A Preparation method of 1, 3-dimethyl-pentylaminehydrochloride SHANGHAI INST TECHNOLOGY 2013-12-25 CN claimed
US-20110064720-A1 Dietary Supplement Compositions and Methods of Making and Using the Same AMATO DANIEL MOSES 2011-03-17 US claimed
US-20110064712-A1 Dietary Supplement Compositions and Methods of Making and Using the Same AMATO DANIEL MOSES 2011-03-17 US claimed
US-20100041622-A1 Compositions containing aminoalkanes and aminoalkane derivatives VIRUN, INC. 2010-02-18 US claimed
WO-2010019255-A1 COMPOSITIONS CONTAINING AMINOALKANES AND AMINOALKANE DERIVATIVES VIRUN, INC. (US) 2010-02-18 WO claimed
CN-113666837-B Preparation method of 1, 4-dimethyl pentylamine hydrochloride 怀化宝华生物科技有限公司 2024-06-07 CN disclosed
CN-117462477-A delivery device PTT控股公司 2024-01-30 CN disclosed
CN-113666837-A Preparation method of 1, 4-dimethyl pentylamine hydrochloride 怀化宝华生物科技有限公司 2021-11-19 CN disclosed
US-20160227832-A1 FORMULATIONS OF WATER-SOLUBLE DERIVATIVES OF VITAMIN E AND COMPOSITIONS CONTAINING SAME VIRUN, INC. 2016-08-11 US disclosed
US-9351517-B2 Formulations of water-soluble derivatives of vitamin E and compositions containing same VIRUN, INC. (US) 2016-05-31 US disclosed
CN-104788320-A Preparation method of 1,3-dimethylbutylamine hydrochloride SHANGHAI XUXIN CHEMICAL CO LTD 2015-07-22 CN disclosed
CN-103467303-B Preparation method of 1, 3-dimethyl-pentylaminehydrochloride SHANGHAI INST TECHNOLOGY 2015-03-04 CN disclosed
CN-103467303-A Preparation method of 1, 3-dimethyl-pentylaminehydrochloride SHANGHAI INST TECHNOLOGY 2013-12-25 CN disclosed
CN-103467303-A Preparation method of 1, 3-dimethyl-pentylaminehydrochloride SHANGHAI INST TECHNOLOGY 2013-12-25 CN disclosed
US-20110064720-A1 Dietary Supplement Compositions and Methods of Making and Using the Same AMATO DANIEL MOSES 2011-03-17 US disclosed
CN-101898969-A Synthesis method of 1,3-dimethylamylamine hydrochloride QIDONG HUDONG CHEMICAL CO LTD 2010-12-01 CN disclosed
CN-101898969-A Synthesis method of 1,3-dimethylamylamine hydrochloride QIDONG HUDONG CHEMICAL CO LTD 2010-12-01 CN disclosed
US-20100041622-A1 Compositions containing aminoalkanes and aminoalkane derivatives VIRUN, INC. 2010-02-18 US disclosed
WO-2010019255-A1 COMPOSITIONS CONTAINING AMINOALKANES AND AMINOALKANE DERIVATIVES VIRUN, INC. (US) 2010-02-18 WO disclosed